Ngozi Chidi-Egboka, OD, MPH, PhD - Becoming a Clinician Par Excellence
Chidi-Egboka shares her passion and path to become a top-notch clinician, academic, researcher and mentor.
In celebration of Women's History Month, ARVONews is featuring a spotlight series on female ARVO members, highlighting their great work and achievements in the field of eye and vision, their journey to this point, and what they envision for the future of the industry. Today we turn the spotlight on María Cecilia Sánchez, PhD — director of the Ocular Neovascularization and Neurodegeneration Laboratory at the Center for Research in Clinical Biochemistry and Immunology (CIBICI) CONICET, National University of Córdoba (Argentina). She is also current president of the Asociación de Investigación en Visión y Oftalmologia (AIVO), an International Chapter Affiliate of ARVO.
Chidi-Egboka shares her passion and path to become a top-notch clinician, academic, researcher and mentor.
Delamere looks back at his long history with ARVO, including his tenure as president, and offers advice to members about the many benefits of volunteering.
Co-founder of two start-up companies developing noninvasive treatment for dry eye and holder of nine granted patents and patent applications, Sher takes us on a journey through her lifelong love of science.
This talented ophthalmologist from Iran was selected as a recipient of the fellowship in 2018, but being an Iranian citizen meant she had to defer acceptance until 2019 when the meeting was in Canada. Dehghani shares her experience at ARVO in her own words.
Cheryl M. Craft, PhD, FARVO, a consistent and outstanding mentor and sponsor to junior women scientists, shares her path as a vision scientist and advice for young researchers.
ARVO welcomes the newest At-Large Members-in-Training Board member, Tasneem Khatib, BM, BCh. Khatib will begin her 2019 - 2021 term as the MIT Trustee on the ARVO Board of Trustees on Oct. 16.
Translational Vision Science and Technology is ARVO's open access, peer-reviewed journal highlighting multidisciplinary research bridging the gap between basic research and clinical care. Learn more about how it fits into the broad spectrum of scientific activity undertaken by ARVO members.
This February, the National Eye Institute (NEI) is celebrating Low Vision Awareness Month by highlighting some of the great resources available for people with low vision along with their eye care providers and family and friends.
Journal of Vision (JOV) is ARVO’s open access, online only, peer-reviewed journal dedicated to the study of functional vision. Learn more about the history, current initiatives and goals of JOV, as well as the impact it has made over the past two decades.
Learn about his eye and vision background in Vietnam, his DCERF Program and ARVO 2022 highlights, plus how he plans to incorporate lessons from his experiences in his future career plans.
Get a glimpse into his professional background as he reflects on his career influences and highlights. He also looks back at his involvement with ARVO over the years and shares the vision for the Association he hopes to accomplish during his tenure.
Share her excitement as she reflects on the highlights of her DCERF experience, top takeaways from ARVO 2022, plus plans she already has underway for ARVO 2023 and her vision for her career.
Kevin Schneider, PhD, a postdoctoral researcher at the Gavin Herbert Eye Institute at University of California Irvine, shares how his 2018 ARVO Foundation Genentech AMD Research Fellowship was an essential jumpstart to pave the way for obtaining consistent research funding.
Learn about Pe’er’s many contributions to ARVO over the years. He also shares his viewpoint on volunteering and the great impact giving back has on you.
Learn about Atherton’s contributions and leadership in ARVO over the years, as she shares a peek behind the curtains on being an ARVO volunteer.
Learn about Hazlett’s contributions to the eye and vision community during her 40-year membership with ARVO and her advice on the benefits of being an ARVO volunteer.